 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Taysha Gene Therapies Inc. (TSHA)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-09-23 Option Award | 2020-09-25 5:08 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Alam Kamran CFO | 331,121 | $0 | 331,121 (Direct) | View |
| 2020-09-23 Option Award | 2020-09-25 5:09 pm | N/A 2030-09-23 | Taysha Gene Therapies Inc. | TSHA | Donenberg Phillip B. Director | 31,000 | $0 | 31,000 (Direct) | View |
| 2020-09-23 Option Award | 2020-09-25 5:11 pm | N/A 2030-09-23 | Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner | 31,000 | $0 | 31,000 (Direct) | View |
| 2020-09-23 Option Award | 2020-09-25 5:12 pm | N/A 2030-09-23 | Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director | 31,000 | $0 | 31,000 (Direct) | View |
| 2020-09-23 Option Award | 2020-09-25 5:13 pm | N/A 2030-09-23 | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director | 31,000 | $0 | 31,000 (Direct) | View |
| 2020-09-23 Option Award | 2020-09-25 5:14 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 668,745 | $0 | 668,745 (Direct) | View |
| 2020-09-28 Conversion | 2020-09-30 4:37 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner | 3,275,205 | $0 | 3,275,205 (Indirect) | View |
| 2020-09-28 Conversion | 2020-09-30 4:37 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner | 2,008,158 | $0 | 2,008,158 (Indirect) | View |
| 2020-09-28 Conversion | 2020-09-30 4:37 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner | 11,944 | $0 | 2,020,102 (Indirect) | View |
| 2020-09-28 Conversion | 2020-09-30 4:37 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner | 3,006,155 | $0 | 0 (Indirect) | View |
| 2020-09-28 Conversion | 2020-09-30 4:37 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner | 1,843,193 | $0 | 0 (Indirect) | View |
| 2020-09-28 Conversion | 2020-09-30 4:37 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Manning Paul B Director 10% Owner | 10,963 | $0 | 0 (Indirect) | View |
| 2020-09-28 Conversion | 2020-09-30 4:37 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director | 19,226 | $0 | 19,226 (Direct) | View |
| 2020-09-28 Conversion | 2020-09-30 4:37 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Nagendran Sukumar Director | 17,647 | $0 | 0 (Direct) | View |
| 2020-09-28 Conversion | 2020-09-30 4:38 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director | 1,089,500 | $0 | 1,089,500 (Indirect) | View |
| 2020-09-28 Conversion | 2020-09-30 4:38 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director | 1,601 | $0 | 1,091,101 (Indirect) | View |
| 2020-09-28 Conversion | 2020-09-30 4:38 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director | 1,000,000 | $0 | 0 (Indirect) | View |
| 2020-09-28 Conversion | 2020-09-30 4:38 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Nolan Sean P. Director | 1,470 | $0 | 0 (Indirect) | View |
| 2020-09-28 Conversion | 2020-09-30 4:39 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 3,844 | $0 | 672,589 (Direct) | View |
| 2020-09-28 Conversion | 2020-09-30 4:39 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 3,529 | $0 | 0 (Direct) | View |
| 2020-11-23 Option Award | 2020-11-24 4:41 pm | N/A 2030-11-23 | Taysha Gene Therapies Inc. | TSHA | Reape Kathleen Director | 31,000 | $0 | 31,000 (Direct) | View |
| 2020-11-23 Option Award | 2020-11-24 4:42 pm | N/A 2030-11-23 | Taysha Gene Therapies Inc. | TSHA | Sepp-Lorenzino Laura Director | 31,000 | $0 | 31,000 (Direct) | View |
| 2021-01-19 Option Award | 2021-01-20 8:20 pm | N/A 2031-01-19 | Taysha Gene Therapies Inc. | TSHA | Alam Kamran CFO | 70,000 | $0 | 70,000 (Direct) | View |
| 2021-01-19 Option Award | 2021-01-20 8:21 pm | N/A 2031-01-19 | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-01-19 Option Award | 2021-01-20 8:22 pm | N/A 2031-01-19 | Taysha Gene Therapies Inc. | TSHA | Session R.A. II CEO 10% Owner | 199,700 | $0 | 199,700 (Direct) | View |